Exponent (EXPO) 10-Q 4 Aug 17 2017 Q2 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	6 Months Ended
	Jun. 30, 2017	Jul. 28, 2017
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2017
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	Q2
Entity Registrant Name	EXPONENT INC
Entity Central Index Key	851,520
Current Fiscal Year End Date	--12-29
Entity Filer Category	Large Accelerated Filer
Trading Symbol	EXPO
Entity Common Stock, Shares Outstanding		25,793,398

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2017	Dec. 30, 2016
Current assets:
Cash and cash equivalents	$ 90,233	$ 114,967
Short-term investments	71,763	58,755
Accounts receivable, net of allowance for contract losses and doubtful accounts of $3,333 and $3,417 at June 30, 2017 and December 30, 2016, respectively	107,444	87,409
Prepaid expenses and other assets	9,283	12,913
Total current assets	278,723	274,044
Property, equipment and leasehold improvements, net	35,892	36,710
Goodwill	8,607	8,607
Deferred income taxes	40,945	42,166
Deferred compensation plan assets	44,590	41,153
Other assets	918	1,064
Total assets	409,675	403,744
Current liabilities:
Accounts payable and accrued liabilities	10,610	10,073
Accrued payroll and employee benefits	50,904	62,539
Deferred revenues	6,602	7,624
Total current liabilities	68,116	80,236
Other liabilities	2,244	2,005
Deferred compensation	48,467	46,503
Deferred rent	1,449	1,654
Total liabilities	120,276	130,398
Stockholders’ equity:
Common stock, $0.001 par value; 80,000 shares authorized; 32,853 shares issued at June 30, 2017 and December 30, 2016	33	33
Additional paid-in capital	206,752	194,632
Accumulated other comprehensive income (loss)
Investment securities, available-for-sale	(142)	(146)
Foreign currency translation adjustments	(2,390)	(2,980)
Accumulated other comprehensive income (loss)	(2,532)	(3,126)
Retained earnings	304,224	291,243
Treasury stock, at cost; 7,060 and 7,256 shares held at June 30, 2017 and December 30, 2016, respectively	(219,078)	(209,436)
Total stockholders’ equity	289,399	273,346
Total liabilities and stockholders’ equity	$ 409,675	$ 403,744

Condensed Consolidated Balance3

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) shares in Thousands, $ in Thousands	Jun. 30, 2017	Dec. 30, 2016
Accounts receivable, net of allowance for contract losses and doubtful accounts	$ 3,333	$ 3,417
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	80,000	80,000
Common stock, shares issued	32,853	32,853
Treasury stock, shares	7,060	7,256

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jul. 01, 2016	Jun. 30, 2017	Jul. 01, 2016
Revenues:
Revenues before reimbursements	$ 84,120	$ 73,334	$ 164,587	$ 152,284
Reimbursements	3,720	3,961	7,375	8,167
Revenues	87,840	77,295	171,962	160,451
Operating expenses:
Compensation and related expenses	51,536	47,040	105,954	99,057
Other operating expenses	7,275	7,218	14,466	14,201
Reimbursable expenses	3,720	3,961	7,375	8,167
General and administrative expenses	4,992	4,145	9,216	7,659
Total operating expenses	67,523	62,364	137,011	129,084
Operating income	20,317	14,931	34,951	31,367
Other income, net:
Interest income, net	266	171	500	310
Miscellaneous income, net	1,765	1,575	4,307	2,734
Total other income, net	2,031	1,746	4,807	3,044
Income before income taxes	22,348	16,677	39,758	34,411
Income taxes	8,557	6,224	9,391	8,608
Net income	$ 13,791	$ 10,453	$ 30,367	$ 25,803
Net income per share:
Basic	$ 0.52	$ 0.39	$ 1.15	$ 0.97
Diluted	$ 0.51	$ 0.38	$ 1.13	$ 0.95
Shares used in per share computations:
Basic	26,415	26,631	26,358	26,572
Diluted	26,968	27,264	26,980	27,256
Cash dividends declared per common share	$ 0.21	$ 0.18	$ 0.42	$ 0.36

Condensed Consolidated Stateme5

Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jul. 01, 2016	Jun. 30, 2017	Jul. 01, 2016
Net income	$ 13,791	$ 10,453	$ 30,367	$ 25,803
Other comprehensive income (loss):
Foreign currency translation adjustments, net of tax	454	(505)	590	(510)
Unrealized (losses) gains on available-for- sale investment securities arising during the period, net of tax	(32)	(1)	4	84
Comprehensive income	$ 14,213	$ 9,947	$ 30,961	$ 25,377

Condensed Consolidated Stateme6

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2017	Jul. 01, 2016
Cash flows from operating activities:
Net income	$ 30,367	$ 25,803
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization of property, equipment and leasehold improvements	3,195	2,927
Amortization of premiums and accretion of discounts on short-term investments	0	14
Deferred rent	(205)	(184)
Provision for contract losses and doubtful accounts	805	1,131
Stock-based compensation	9,187	7,929
Deferred income tax provision	1,217	424
Changes in operating assets and liabilities:
Accounts receivable	(20,840)	(4,863)
Prepaid expenses and other assets	3,365	(5,198)
Accounts payable and accrued liabilities	928	(1,716)
Accrued payroll and employee benefits	(9,806)	(9,712)
Deferred revenues	(1,022)	(2,010)
Net cash provided by operating activities	17,191	14,545
Cash flows from investing activities:
Capital expenditures	(2,526)	(3,382)
Purchase of short-term investments	(13,000)	(24,000)
Maturity of short-term investments	0	21,450
Net cash used in investing activities	(15,526)	(5,932)
Cash flows from financing activities:
Payroll taxes for restricted stock units	(9,520)	(7,613)
Repurchase of common stock	(7,004)	(4,458)
Exercise of share-based payment awards	638	1,229
Dividends and dividend equivalents rights	(10,995)	(9,515)
Net cash used in financing activities	(26,881)	(20,357)
Effect of foreign currency exchange rates on cash and cash equivalents	482	(464)
Net decrease in cash and cash equivalents	(24,734)	(12,208)
Cash and cash equivalents at beginning of period	114,967	125,751
Cash and cash equivalents at end of period	$ 90,233	$ 113,543

Basis of Presentation

Basis of Presentation	6 Months Ended
	Jun. 30, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Note 1: Exponent, Inc. (referred to as the “Company” or “Exponent”) is an engineering and scientific consulting firm that provides solutions to complex problems. The Company operates on a 52-53 week fiscal year ending on the Friday closest to the last day of December. The accompanying unaudited condensed consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information, the instructions to Form 10-Q and Article 10 of Regulation S-X promulgated by the Securities and Exchange Commission. Accordingly, they do not contain all the information and notes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, all adjustments which are necessary for the fair presentation of the condensed consolidated financial statements have been included and all such adjustments are of a normal and recurring nature. The operating results for the three and six months ended June 30, 2017 are not necessarily representative of the results of future quarterly or annual periods. The following information should be read in conjunction with the audited consolidated financial statements and accompanying notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 30, 2016, which was filed with the U.S. Securities and Exchange Commission on February 24, 2017. The unaudited condensed consolidated financial statements include the accounts of Exponent, Inc. and its subsidiaries, which are all wholly owned. All intercompany accounts and transactions have been eliminated in consolidation. Dividend. Fiscal Year 2017 Dividends Amount Per Share (in thousands) First Quarter $ 0.21 $ 5,374 Second Quarter 0.21 5,424 Total $ 0.42 $ 10,798 Fiscal Year 2016 Dividends Amount Per Share (in thousands) First Quarter $ 0.18 $ 4,628 Second Quarter 0.18 4,675 Third Quarter 0.18 4,659 Fourth Quarter 0.18 4,607 Total $ 0.72 $ 18,569 On July 18, 2017 0.21 September 22, 2017 September 1, 2017 The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Significant items subject to such estimates and assumptions include accounting for revenue recognition and estimating the allowance for contract losses and doubtful accounts. Actual results could differ from those estimates. . On May 28, 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers The impact of adopting the new standard is not expected to be material because the analysis of the Company’s contracts under the new revenue recognition standard supports the recognition of revenue over time, which is consistent with the Company’s current revenue recognition model. Substantially all of the Company’s engagements are performed under time and material or fixed-price arrangements. For time and materials contracts the Company anticipates utilizing the practical expedient under the ASU which states, if an entity has a right to consideration from a customer in an amount that corresponds directly with the value of the entity’s performance completed to date (for example, a service contract in which an entity bills a fixed amount for each hour or service provided), the entity may recognize revenue in the amount to which the entity has a right to invoice. Application of the practical expedient to time and material contracts is consistent with the Company’s current revenue recognition policy. For fixed price contracts the Company will recognize revenue over time under the ASU because of the continuous transfer of control to the customer. The customer typically controls the work in process as evidenced either by contractual termination clauses or by the Company’s rights to payment for work performed to date to deliver services that do not have an alternative use to the Company. Input methods are an acceptable method of measuring progress towards completing under the ASU. This is consistent with the Company’s current policy of measuring progress towards completion based on the relationship of incurred labor hours at standard rates to its estimate of the total labor hours at standard rates it expects to incur over the term of the contract. The Company believes this methodology achieves a reliable measure of the revenue from the consulting services it provides to its customers under fixed price contracts. The Company anticipates adopting the standard using the modified retrospective method. The Company is currently evaluating the required disclosures under the new standard and developing appropriate changes to its process, systems and controls. On February 25, 2016, the FASB issued ASU No. 2016-02, Leases

Fair Value Measurements

Fair Value Measurements	6 Months Ended
	Jun. 30, 2017
Fair Value Disclosures [Abstract]
Fair Value Measurements	Note 2: Fair Value Measurements The Company measures certain financial assets and liabilities at fair value on a recurring basis, including available-for-sale fixed income securities, trading fixed income and equity securities held in its deferred compensation plan and the liability associated with its deferred compensation plan. There were no transfers between fair value measurement levels during the three and six months ended June 30, 2017 and July 1, 2016. Any transfers between fair value measurement levels would be recorded on the actual date of the event or change in circumstances that caused the transfer. Fair Value Measurements at Reporting Date Using Quoted Prices in Significant Active Markets for Significant Other Unobservable Identical Assets Observable Inputs Inputs (In thousands) Total (Level 1) (Level 2) (Level 3) Assets Money market securities (1) $ 9,259 $ 9,259 $ - $ - Fixed income available- for-sale securities (2) 71,763 - 71,763 - Fixed income trading securities held in deferred compensation plan (3) 14,033 14,033 - - Equity trading securities held in deferred compensation plan (3) 34,637 34,637 - - Total $ 129,692 $ 57,929 $ 71,763 $ - Liabilities Deferred compensation plan (4) 54,082 54,082 - - Total $ 54,082 $ 54,082 $ - $ - (1) Included in cash and cash equivalents on the Company’s unaudited condensed consolidated balance sheet. (2) Included in short-term investments on the Company’s unaudited condensed consolidated balance sheet. (3) Included in prepaid expenses and other assets and deferred compensation plan assets on the Company’s unaudited condensed consolidated balance sheet. (4) Included in accrued payroll and employee benefits and deferred compensation on the Company’s unaudited condensed consolidated balance sheet. The fair value of these certain financial assets and liabilities was determined using the following inputs at December 30, 2016: Fair Value Measurements at Reporting Date Using Quoted Prices in Significant Active Markets for Significant Other Unobservable Identical Assets Observable Inputs Inputs (In thousands) Total (Level 1) (Level 2) (Level 3) Assets Money market securities (1) $ 21,918 $ 21,918 $ - $ - Fixed income available- for-sale securities (2) 58,755 - 58,755 - Fixed income trading securities held in deferred compensation plan (3) 11,872 11,872 - - Equity trading securities held in deferred compensation plan (3) 36,395 36,395 - - Total $ 128,940 $ 70,185 $ 58,755 $ - Liabilities Deferred compensation plan (4) 53,617 53,617 - - Total $ 53,617 $ 53,617 $ - $ - (1) Included in cash and cash equivalents on the Company’s unaudited condensed consolidated balance sheet. (2) Included in short-term investments on the Company’s unaudited condensed consolidated balance sheet. (3) Included in prepaid expenses and other assets and deferred compensation plan assets on the Company’s unaudited condensed consolidated balance sheet. (4) Included in accrued payroll and employee benefits and deferred compensation on the Company’s unaudited condensed consolidated balance sheet. Fixed income available-for-sale securities as of June 30, 2017 and December 30, 2016 represent obligations of United States agencies. Fixed income and equity trading securities represent mutual funds held in the Company’s deferred compensation plan. See Note 6 for additional information about the Company’s deferred compensation plan. Amortized Unrealized Unrealized Estimated (In thousands) Cost Gains Losses Fair Value Classified as current assets: Cash $ 80,974 $ - $ - $ 80,974 Cash equivalents: Money market securities 9,259 - - 9,259 Total cash equivalents 9,259 - - 9,259 Total cash and cash equivalents 90,233 - - 90,233 Short-term investments: U.S. agency securities 72,000 - (237) 71,763 Total short-term investments 72,000 - (237) 71,763 Total cash, cash equivalents and short-term investments $ 162,233 $ - $ (237) $ 161,996 Cash, cash equivalents and short-term investments consisted of the following as of December 30, 2016: Amortized Unrealized Unrealized Estimated (In thousands) Cost Gains Losses Fair Value Classified as current assets: Cash $ 93,049 $ - $ - $ 93,049 Cash equivalents: Money market securities 21,918 - - 21,918 Total cash equivalents 21,918 - - 21,918 Total cash and cash equivalents 114,967 - - 114,967 Short-term investments: U.S. agency securities 59,000 - (245) 58,755 Total short-term investments 59,000 - (245) 58,755 Total cash, cash equivalents and short-term investments $ 173,967 $ - $ (245) $ 173,722 Amortized Estimated (In thousands) Cost Fair Value Due within one year $ 32,000 $ 31,936 Due between one and two years 40,000 39,827 Total $ 72,000 $ 71,763 At June 30, 2017 and December 30, 2016, the Company did not have any assets or liabilities valued using significant unobservable inputs. The following financial instruments are not measured at fair value on the Company's consolidated balance sheet at June 30, 2017 and December 30, 2016, but require disclosure of their fair values: accounts receivable, other assets and accounts payable. The estimated fair value of such instruments at June 30, 2017 and December 30, 2016 approximates their carrying value as reported on the consolidated balance sheet. There were no other-than-temporary impairments or credit losses related to available-for-sale securities during the three and six months ended June 30, 2017 and July 1, 2016.

Net Income Per Share

Net Income Per Share	6 Months Ended
	Jun. 30, 2017
Earnings Per Share [Abstract]
Net Income Per Share	Note 3: Net Income Per Share Basic per share amounts are computed using the weighted-average number of common shares outstanding during the period. Diluted per share amounts are calculated using the weighted-average number of common shares outstanding during the period and, when dilutive, the weighted-average number of potential common shares from the issuance of common stock to satisfy outstanding restricted stock units and the exercise of outstanding options to purchase common stock using the treasury stock method. Three Months Ended Six Months Ended June 30, July 1, June 30, July 1, (In thousands) 2017 2016 2017 2016 Shares used in basic per share computation 26,415 26,631 26,358 26,572 Effect of dilutive common stock options outstanding 135 127 133 124 Effect of dilutive restricted stock units outstanding 418 506 489 560 Shares used in diluted per share computation 26,968 27,264 26,980 27,256 There were no options excluded from the diluted per share calculations for the three and six months ended June 30, 2017 and July 1, 2016.

Stock-Based Compensation

Stock-Based Compensation	6 Months Ended
	Jun. 30, 2017
Share-based Compensation [Abstract]
Stock-Based Compensation	Note 4: Stock-Based Compensation Restricted Stock Units Restricted stock unit grants are designed to attract and retain employees, and to better align employee interests with those of the Company’s stockholders. For a select group of employees, up to 40 The value of these restricted stock unit awards is determined based on the market price of the Company’s common stock on the date of grant. The value of fully vested restricted stock unit awards issued is recorded as a reduction to accrued bonuses. The portion of bonus expense that the Company expects to settle with fully vested restricted stock unit awards is recorded as stock-based compensation during the period the bonus is earned. The Company recorded stock-based compensation expense associated with accrued bonus awards of $ 2,201,000 1,451,000 4,129,000 3,168,000 1,238,000 1,206,000 4,494,000 4,332,000 Stock Options Stock options are granted for terms of ten years and generally vest 25 93,000 52,000 564,000 429,000 The Company uses the Black-Scholes option-pricing model to determine the fair value of options granted. The determination of the fair value of stock option awards on the date of grant using an option-pricing model is affected by the Company’s stock price as well as assumptions regarding a number of complex and subjective variables. These variables include expected stock price volatility over the term of the award, actual and projected employee stock option exercise behaviors, the risk-free interest rate and expected dividends. The Company used historical exercise and post-vesting forfeiture and expiration data to estimate the expected term of options granted. The historical volatility of the Company’s common stock over a period of time equal to the expected term of the options granted was used to estimate expected volatility. The risk-free interest rate used in the option-pricing model was based on United States Treasury zero-coupon issues with remaining terms similar to the expected term of the options. The dividend yield assumption considers the expectation of continued declaration of dividends, offset by option holders’ dividend equivalent rights. The Company accounts for forfeitures of stock-based awards when they occur. All stock-based payment awards are recognized on a straight-line basis over the requisite service periods of the awards.

Treasury Stock

Treasury Stock	6 Months Ended
	Jun. 30, 2017
Equity [Abstract]
Treasury Stock	Note 5: Treasury Stock On October 21, 2015, the Company’s Board of Directors authorized $ 35,000,000 35,000,000 The Company repurchased 117,582 7,004,000 90,505 4,458,000 50,303,000 Net losses related to the re-issuance of treasury stock to settle restricted stock unit and stock option awards of $ 5,667,000 5,791,000

Deferred Compensation Plans

Deferred Compensation Plans	6 Months Ended
	Jun. 30, 2017
Deferred Compensation Arrangements [Abstract]
Deferred Compensation Plans	Note 6: Deferred Compensation Plans The Company maintains nonqualified deferred compensation plans for the benefit of a select group of highly compensated employees. Under these plans, participants may elect to defer up to 100 48,670,000 48,267,000 As of June 30, 2017 and December 30, 2016, vested amounts due under the plans totaled $ 54,082,000 53,617,000 1,020,000 938,000 2,917,000 1,366,000

Supplemental Cash Flow Informat

Supplemental Cash Flow Information	6 Months Ended
	Jun. 30, 2017
Supplemental Cash Flow Information [Abstract]
Supplemental Cash Flow Information	Note 7: Supplemental Cash Flow Information Six Months Ended (In thousands) June 30, 2017 July 1, 2016 Cash paid during period: Income taxes $ 8,522 $ 11,808 Non-cash investing and financing activities: Unrealized gain on short-term investments $ 4 $ 84 Vested stock unit awards issued to settle accrued bonuses $ 6,910 $ 6,334 Accrual for capital expenditures $ 135 $ 422

Accounts Receivable, Net

Accounts Receivable, Net	6 Months Ended
	Jun. 30, 2017
Receivables [Abstract]
Accounts Receivable, Net	Note 8: Accounts Receivable, Net June 30, December 30, (In thousands) 2017 2016 Billed accounts receivable $ 72,915 $ 60,510 Unbilled accounts receivable 37,862 30,316 Allowance for contract losses and doubtful accounts (3,333) (3,417) Total accounts receivable, net $ 107,444 $ 87,409

Segment Reporting

Segment Reporting	6 Months Ended
	Jun. 30, 2017
Segment Reporting [Abstract]
Segment Reporting	Note 9: Segment Reporting The Company has two reportable operating segments based on two primary areas of service. The Engineering and Other Scientific segment is a broad service group providing technical consulting in different practices primarily in engineering. The Environmental and Health segment provides services in the area of environmental, epidemiology and health risk analysis. This segment provides a wide range of consulting services relating to environmental hazards and risks and the impact on both human health and the environment. Revenues Three Months Ended Six Months Ended (In thousands) June 30, 2017 July 1, 2016 June 30, 2017 July 1, 2016 Engineering and Other Scientific $ 69,795 $ 60,979 $ 136,478 $ 125,789 Environmental and Health 18,045 16,316 35,484 34,662 Total revenues $ 87,840 $ 77,295 $ 171,962 $ 160,451 Operating Income Three Months Ended Six Months Ended (In thousands) June 30, 2017 July 1, 2016 June 30, 2017 July 1, 2016 Engineering and Other Scientific $ 24,313 $ 19,561 $ 46,634 $ 40,699 Environmental and Health 5,824 4,028 11,303 9,223 Total segment operating income 30,137 23,589 57,937 49,922 Corporate operating expense (9,820) (8,658) (22,986) (18,555) Total operating income $ 20,317 $ 14,931 $ 34,951 $ 31,367 Capital Expenditures Three Months Ended Six Months Ended (In thousands) June 30, 2017 July 1, 2016 June 30, 2017 July 1, 2016 Engineering and Other Scientific $ 794 $ 1,273 $ 1,802 $ 2,463 Environmental and Health 64 38 106 61 Total segment capital expenditures 858 1,311 1,908 2,524 Corporate capital expenditures 361 590 618 858 Total capital expenditures $ 1,219 $ 1,901 $ 2,526 $ 3,382 Depreciation and Amortization Three Months Ended Six Months Ended (In thousands) June 30, 2017 July 1, 2016 June 30, 2017 July 1, 2016 Engineering and Other Scientific $ 1,163 $ 1,116 $ 2,278 $ 2,137 Environmental and Health 44 45 85 88 Total segment depreciation and amortization 1,207 1,161 2,363 2,225 Corporate depreciation and amortization 422 363 832 702 Total depreciation and amortization $ 1,629 $ 1,524 $ 3,195 $ 2,927 One customer comprised 12 10 10 12 10

Contingencies

Contingencies	6 Months Ended
	Jun. 30, 2017
Commitments and Contingencies Disclosure [Abstract]
Contingencies	Note 10: Contingencies The Company is a party to various legal actions from time to time and may be contingently liable in connection with claims and contracts arising in the normal course of business, the outcome of which the Company believes, after consultation with legal counsel, will not have a material adverse effect on its financial condition, results of operations or liquidity. However, due to the risks and uncertainties inherent in legal proceedings, actual results could differ from current expected results. All legal costs associated with litigation are expensed as incurred.

Basis of Presentation (Policies

Basis of Presentation (Policies)	6 Months Ended
	Jun. 30, 2017
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation Exponent, Inc. (referred to as the “Company” or “Exponent”) is an engineering and scientific consulting firm that provides solutions to complex problems. The Company operates on a 52-53 week fiscal year ending on the Friday closest to the last day of December. The accompanying unaudited condensed consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information, the instructions to Form 10-Q and Article 10 of Regulation S-X promulgated by the Securities and Exchange Commission. Accordingly, they do not contain all the information and notes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, all adjustments which are necessary for the fair presentation of the condensed consolidated financial statements have been included and all such adjustments are of a normal and recurring nature. The operating results for the three and six months ended June 30, 2017 are not necessarily representative of the results of future quarterly or annual periods. The following information should be read in conjunction with the audited consolidated financial statements and accompanying notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 30, 2016, which was filed with the U.S. Securities and Exchange Commission on February 24, 2017. The unaudited condensed consolidated financial statements include the accounts of Exponent, Inc. and its subsidiaries, which are all wholly owned. All intercompany accounts and transactions have been eliminated in consolidation.
Use of Estimates	Use of Estimates. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Significant items subject to such estimates and assumptions include accounting for revenue recognition and estimating the allowance for contract losses and doubtful accounts. Actual results could differ from those estimates.
Recent Accounting Pronouncements Not Yet Effective	Recent Accounting Pronouncements Not Yet Effective . On May 28, 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers The impact of adopting the new standard is not expected to be material because the analysis of the Company’s contracts under the new revenue recognition standard supports the recognition of revenue over time, which is consistent with the Company’s current revenue recognition model. Substantially all of the Company’s engagements are performed under time and material or fixed-price arrangements. For time and materials contracts the Company anticipates utilizing the practical expedient under the ASU which states, if an entity has a right to consideration from a customer in an amount that corresponds directly with the value of the entity’s performance completed to date (for example, a service contract in which an entity bills a fixed amount for each hour or service provided), the entity may recognize revenue in the amount to which the entity has a right to invoice. Application of the practical expedient to time and material contracts is consistent with the Company’s current revenue recognition policy. For fixed price contracts the Company will recognize revenue over time under the ASU because of the continuous transfer of control to the customer. The customer typically controls the work in process as evidenced either by contractual termination clauses or by the Company’s rights to payment for work performed to date to deliver services that do not have an alternative use to the Company. Input methods are an acceptable method of measuring progress towards completing under the ASU. This is consistent with the Company’s current policy of measuring progress towards completion based on the relationship of incurred labor hours at standard rates to its estimate of the total labor hours at standard rates it expects to incur over the term of the contract. The Company believes this methodology achieves a reliable measure of the revenue from the consulting services it provides to its customers under fixed price contracts. The Company anticipates adopting the standard using the modified retrospective method. The Company is currently evaluating the required disclosures under the new standard and developing appropriate changes to its process, systems and controls. On February 25, 2016, the FASB issued ASU No. 2016-02, Leases

Basis of Presentation (Tables)

Basis of Presentation (Tables)	6 Months Ended
	Jun. 30, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Common Stock Dividends Declared Per Share	The Company declared and paid cash dividends per common share during the periods presented as follows: Fiscal Year 2017 Dividends Amount Per Share (in thousands) First Quarter $ 0.21 $ 5,374 Second Quarter 0.21 5,424 Total $ 0.42 $ 10,798 Fiscal Year 2016 Dividends Amount Per Share (in thousands) First Quarter $ 0.18 $ 4,628 Second Quarter 0.18 4,675 Third Quarter 0.18 4,659 Fourth Quarter 0.18 4,607 Total $ 0.72 $ 18,569

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended
	Jun. 30, 2017
Fair Value Disclosures [Abstract]
Assets and Liabilities Measured at Fair Value on Recurring Basis	The fair value of these certain financial assets and liabilities was determined using the following inputs at June 30, 2017: Fair Value Measurements at Reporting Date Using Quoted Prices in Significant Active Markets for Significant Other Unobservable Identical Assets Observable Inputs Inputs (In thousands) Total (Level 1) (Level 2) (Level 3) Assets Money market securities (1) $ 9,259 $ 9,259 $ - $ - Fixed income available- for-sale securities (2) 71,763 - 71,763 - Fixed income trading securities held in deferred compensation plan (3) 14,033 14,033 - - Equity trading securities held in deferred compensation plan (3) 34,637 34,637 - - Total $ 129,692 $ 57,929 $ 71,763 $ - Liabilities Deferred compensation plan (4) 54,082 54,082 - - Total $ 54,082 $ 54,082 $ - $ - (1) Included in cash and cash equivalents on the Company’s unaudited condensed consolidated balance sheet. (2) Included in short-term investments on the Company’s unaudited condensed consolidated balance sheet. (3) Included in prepaid expenses and other assets and deferred compensation plan assets on the Company’s unaudited condensed consolidated balance sheet. (4) Included in accrued payroll and employee benefits and deferred compensation on the Company’s unaudited condensed consolidated balance sheet. The fair value of these certain financial assets and liabilities was determined using the following inputs at December 30, 2016: Fair Value Measurements at Reporting Date Using Quoted Prices in Significant Active Markets for Significant Other Unobservable Identical Assets Observable Inputs Inputs (In thousands) Total (Level 1) (Level 2) (Level 3) Assets Money market securities (1) $ 21,918 $ 21,918 $ - $ - Fixed income available- for-sale securities (2) 58,755 - 58,755 - Fixed income trading securities held in deferred compensation plan (3) 11,872 11,872 - - Equity trading securities held in deferred compensation plan (3) 36,395 36,395 - - Total $ 128,940 $ 70,185 $ 58,755 $ - Liabilities Deferred compensation plan (4) 53,617 53,617 - - Total $ 53,617 $ 53,617 $ - $ - (1) Included in cash and cash equivalents on the Company’s unaudited condensed consolidated balance sheet. (2) Included in short-term investments on the Company’s unaudited condensed consolidated balance sheet. (3) Included in prepaid expenses and other assets and deferred compensation plan assets on the Company’s unaudited condensed consolidated balance sheet. (4) Included in accrued payroll and employee benefits and deferred compensation on the Company’s unaudited condensed consolidated balance sheet.
Cash, cash equivalents and short-term investments	Cash, cash equivalents and short-term investments consisted of the following as of June 30, 2017: Amortized Unrealized Unrealized Estimated (In thousands) Cost Gains Losses Fair Value Classified as current assets: Cash $ 80,974 $ - $ - $ 80,974 Cash equivalents: Money market securities 9,259 - - 9,259 Total cash equivalents 9,259 - - 9,259 Total cash and cash equivalents 90,233 - - 90,233 Short-term investments: U.S. agency securities 72,000 - (237) 71,763 Total short-term investments 72,000 - (237) 71,763 Total cash, cash equivalents and short-term investments $ 162,233 $ - $ (237) $ 161,996 Cash, cash equivalents and short-term investments consisted of the following as of December 30, 2016: Amortized Unrealized Unrealized Estimated (In thousands) Cost Gains Losses Fair Value Classified as current assets: Cash $ 93,049 $ - $ - $ 93,049 Cash equivalents: Money market securities 21,918 - - 21,918 Total cash equivalents 21,918 - - 21,918 Total cash and cash equivalents 114,967 - - 114,967 Short-term investments: U.S. agency securities 59,000 - (245) 58,755 Total short-term investments 59,000 - (245) 58,755 Total cash, cash equivalents and short-term investments $ 173,967 $ - $ (245) $ 173,722
Summary of Cost and Estimated Fair Value of Short Term Fixed Income Securities	The following table summarizes the cost and estimated fair value of short-term fixed income securities classified as short-term investments based on stated effective maturities as of June 30, 2017: Amortized Estimated (In thousands) Cost Fair Value Due within one year $ 32,000 $ 31,936 Due between one and two years 40,000 39,827 Total $ 72,000 $ 71,763

Net Income Per Share (Tables)

Net Income Per Share (Tables)	6 Months Ended
	Jun. 30, 2017
Earnings Per Share [Abstract]
Reconciles Shares to Calculate Basic and Diluted Net Income Per Share	The following schedule reconciles the shares used to calculate basic and diluted net income per share: Three Months Ended Six Months Ended June 30, July 1, June 30, July 1, (In thousands) 2017 2016 2017 2016 Shares used in basic per share computation 26,415 26,631 26,358 26,572 Effect of dilutive common stock options outstanding 135 127 133 124 Effect of dilutive restricted stock units outstanding 418 506 489 560 Shares used in diluted per share computation 26,968 27,264 26,980 27,256

Supplemental Cash Flow Inform21

Supplemental Cash Flow Information (Tables)	6 Months Ended
	Jun. 30, 2017
Supplemental Cash Flow Information [Abstract]
Supplemental Disclosure of Cash Flow Information	The following is supplemental disclosure of cash flow information: Six Months Ended (In thousands) June 30, 2017 July 1, 2016 Cash paid during period: Income taxes $ 8,522 $ 11,808 Non-cash investing and financing activities: Unrealized gain on short-term investments $ 4 $ 84 Vested stock unit awards issued to settle accrued bonuses $ 6,910 $ 6,334 Accrual for capital expenditures $ 135 $ 422

Accounts Receivable, Net (Table

Accounts Receivable, Net (Tables)	6 Months Ended
	Jun. 30, 2017
Receivables [Abstract]
Accounts Receivable, Net	At June 30, 2017 and December 30, 2016, accounts receivable, net, was comprised of the following: June 30, December 30, (In thousands) 2017 2016 Billed accounts receivable $ 72,915 $ 60,510 Unbilled accounts receivable 37,862 30,316 Allowance for contract losses and doubtful accounts (3,333) (3,417) Total accounts receivable, net $ 107,444 $ 87,409

Segment Reporting (Tables)

Segment Reporting (Tables)	6 Months Ended
	Jun. 30, 2017
Segment Reporting [Abstract]
Segment Reporting Information, by Segment	Segment information for the three and six months ended June 30, 2017 and July 1, 2016 follows: Revenues Three Months Ended Six Months Ended (In thousands) June 30, 2017 July 1, 2016 June 30, 2017 July 1, 2016 Engineering and Other Scientific $ 69,795 $ 60,979 $ 136,478 $ 125,789 Environmental and Health 18,045 16,316 35,484 34,662 Total revenues $ 87,840 $ 77,295 $ 171,962 $ 160,451 Operating Income Three Months Ended Six Months Ended (In thousands) June 30, 2017 July 1, 2016 June 30, 2017 July 1, 2016 Engineering and Other Scientific $ 24,313 $ 19,561 $ 46,634 $ 40,699 Environmental and Health 5,824 4,028 11,303 9,223 Total segment operating income 30,137 23,589 57,937 49,922 Corporate operating expense (9,820) (8,658) (22,986) (18,555) Total operating income $ 20,317 $ 14,931 $ 34,951 $ 31,367 Capital Expenditures Three Months Ended Six Months Ended (In thousands) June 30, 2017 July 1, 2016 June 30, 2017 July 1, 2016 Engineering and Other Scientific $ 794 $ 1,273 $ 1,802 $ 2,463 Environmental and Health 64 38 106 61 Total segment capital expenditures 858 1,311 1,908 2,524 Corporate capital expenditures 361 590 618 858 Total capital expenditures $ 1,219 $ 1,901 $ 2,526 $ 3,382 Depreciation and Amortization Three Months Ended Six Months Ended (In thousands) June 30, 2017 July 1, 2016 June 30, 2017 July 1, 2016 Engineering and Other Scientific $ 1,163 $ 1,116 $ 2,278 $ 2,137 Environmental and Health 44 45 85 88 Total segment depreciation and amortization 1,207 1,161 2,363 2,225 Corporate depreciation and amortization 422 363 832 702 Total depreciation and amortization $ 1,629 $ 1,524 $ 3,195 $ 2,927

Basis of Presentation - Additio

Basis of Presentation - Additional Information (Detail) - Subsequent Event	1 Months Ended
	Jul. 18, 2017$ / shares
Class of Stock [Line Items]
Common stock, dividends per share declared, subsequent event	$ 0.21
Dividends Payable, Date Declared	Jul. 18, 2017
Dividends Payable, Date to be Paid	Sep. 22, 2017
Dividends Payable, Date of Record	Sep. 1, 2017

Common Stock Dividends Declared

Common Stock Dividends Declared And Paid Per Share (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended						6 Months Ended	12 Months Ended
	Jun. 30, 2017	Mar. 31, 2017	Dec. 30, 2016	Sep. 30, 2016	Jul. 01, 2016	Apr. 01, 2016	Jun. 30, 2017	Dec. 30, 2016
Class of Stock [Line Items]
Dividends Per Share	$ 0.21	$ 0.21	$ 0.18	$ 0.18	$ 0.18	$ 0.18	$ 0.42	$ 0.72
Amount	$ 5,424	$ 5,374	$ 4,607	$ 4,659	$ 4,675	$ 4,628	$ 10,798	$ 18,569

Assets and Liabilities Measured

Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) - USD ($) $ in Thousands		Jun. 30, 2017	Dec. 30, 2016
Assets
Money market securities	[1]	$ 9,259	$ 21,918
Total		129,692	128,940
Liabilities
Deferred compensation plan	[2]	54,082	53,617
Total		54,082	53,617
Fixed income securities
Assets
Fixed income available-for-sale securities	[3]	71,763	58,755
Fixed income trading securities held in deferred compensation plan	[4]	14,033	11,872
Equity securities
Assets
Equity trading securities held in deferred compensation plan	[4]	34,637	36,395
Fair Value, Inputs, Level 1
Assets
Money market securities	[1]	9,259	21,918
Total		57,929	70,185
Liabilities
Deferred compensation plan	[2]	54,082	53,617
Total		54,082	53,617
Fair Value, Inputs, Level 1 | Fixed income securities
Assets
Fixed income available-for-sale securities	[3]	0	0
Fixed income trading securities held in deferred compensation plan	[4]	14,033	11,872
Fair Value, Inputs, Level 1 | Equity securities
Assets
Equity trading securities held in deferred compensation plan	[4]	34,637	36,395
Fair Value, Inputs, Level 2
Assets
Money market securities	[1]	0	0
Total		71,763	58,755
Liabilities
Deferred compensation plan	[2]	0	0
Total		0	0
Fair Value, Inputs, Level 2 | Fixed income securities
Assets
Fixed income available-for-sale securities	[3]	71,763	58,755
Fixed income trading securities held in deferred compensation plan	[4]	0	0
Fair Value, Inputs, Level 2 | Equity securities
Assets
Equity trading securities held in deferred compensation plan	[4]	0	0
Fair Value, Inputs, Level 3
Assets
Money market securities	[1]	0	0
Total		0	0
Liabilities
Deferred compensation plan	[2]	0	0
Total		0	0
Fair Value, Inputs, Level 3 | Fixed income securities
Assets
Fixed income available-for-sale securities	[3]	0	0
Fixed income trading securities held in deferred compensation plan	[4]	0	0
Fair Value, Inputs, Level 3 | Equity securities
Assets
Equity trading securities held in deferred compensation plan	[4]	$ 0	$ 0
[1]	Included in cash and cash equivalents on the Company’s unaudited condensed consolidated balance sheet.
[2]	Included in accrued payroll and employee benefits and deferred compensation on the Company’s unaudited condensed consolidated balance sheet.
[3]	Included in short-term investments on the Company’s unaudited condensed consolidated balance sheet.
[4]	Included in prepaid expenses and other assets and deferred compensation plan assets on the Company’s unaudited condensed consolidated balance sheet.

Cash, cash equivalents and shor

Cash, cash equivalents and short-term investments (Detail) - USD ($) $ in Thousands	Jun. 30, 2017	Dec. 30, 2016
Fair Value Measurements [Line Items]
Amortized Cost	$ 162,233	$ 173,967
Unrealized Gains	0	0
Unrealized Losses	(237)	(245)
Estimated Fair Value	161,996	173,722
U.S. agency securities
Fair Value Measurements [Line Items]
Amortized Cost	72,000	59,000
Unrealized Gains	0	0
Unrealized Losses	(237)	(245)
Estimated Fair Value	71,763	58,755
Cash
Fair Value Measurements [Line Items]
Amortized Cost	80,974	93,049
Unrealized Gains	0	0
Unrealized Losses	0	0
Estimated Fair Value	80,974	93,049
Money market securities
Fair Value Measurements [Line Items]
Amortized Cost	9,259	21,918
Unrealized Gains	0	0
Unrealized Losses	0	0
Estimated Fair Value	9,259	21,918
Total cash equivalents
Fair Value Measurements [Line Items]
Amortized Cost	9,259	21,918
Unrealized Gains	0	0
Unrealized Losses	0	0
Estimated Fair Value	9,259	21,918
Total cash and cash equivalents
Fair Value Measurements [Line Items]
Amortized Cost	90,233	114,967
Unrealized Gains	0	0
Unrealized Losses	0	0
Estimated Fair Value	90,233	114,967
Total short-term investments
Fair Value Measurements [Line Items]
Amortized Cost	72,000	59,000
Unrealized Gains	0	0
Unrealized Losses	(237)	(245)
Estimated Fair Value	$ 71,763	$ 58,755

Summarizes Cost And Estimated F

Summarizes Cost And Estimated Fair Value Of Short Term Fixed Income Securities (Detail) - USD ($) $ in Thousands	Jun. 30, 2017	Dec. 30, 2016
Fair Value Measurements [Line Items]
Due within one year, Amortized Cost	$ 32,000
Due between one and two years, Amortized Cost	40,000
Total Amortized Cost	72,000
Due within one year, Estimated Fair Value	31,936
Due between one and two years, Estimated Fair Value	39,827
Total Estimated Fair Value	$ 71,763	$ 58,755

Reconciliation of Shares Used t

Reconciliation of Shares Used to Calculate Basic and Diluted Net Income Per Share (Detail) - shares shares in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jul. 01, 2016	Jun. 30, 2017	Jul. 01, 2016
Schedule Of Earnings Per Share Basic and Diluted [Line Items]
Shares used in basic per share computation	26,415	26,631	26,358	26,572
Shares used in diluted per share computation	26,968	27,264	26,980	27,256
Employee Stock Option
Schedule Of Earnings Per Share Basic and Diluted [Line Items]
Effect of dilutive stock outstanding	135	127	133	124
Restricted Stock Units (RSUs)
Schedule Of Earnings Per Share Basic and Diluted [Line Items]
Effect of dilutive stock outstanding	418	506	489	560

Stock-Based Compensation - Addi

Stock-Based Compensation - Additional Information (Detail) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jul. 01, 2016	Jun. 30, 2017	Jul. 01, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share Based Compensation Arrangement By Share Based Payment Award Options Expiration Term			10 years
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of annual bonus settled with fully vested restricted stock unit awards			40.00%
Unvested Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock based compensation, vesting period			4 years
Employee Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock based compensation expense	$ 93,000	$ 52,000	$ 564,000	$ 429,000
Vesting percentage of stock options granted per year			25.00%
Stock based compensation, vesting period			4 years
Vested Restricted Stock Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock based compensation expense	2,201,000	1,451,000	$ 4,129,000	3,168,000
Stock based compensation, holding period			4 years
Vested Restricted Stock Awards | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Recipient age to expense award on grant date			59 years 6 months
Unvested Restricted Stock Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock based compensation expense	$ 1,238,000	$ 1,206,000	$ 4,494,000	$ 4,332,000
Unvested Restricted Stock Awards | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Recipient age to expense award on grant date			59 years 6 months
Unvested Stock Options | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Recipient age to expense award on grant date			59 years 6 months

Treasury Stock - Additional Inf

Treasury Stock - Additional Information (Detail) - USD ($)	6 Months Ended
	Jun. 30, 2017	Jul. 01, 2016	Oct. 19, 2016	Oct. 21, 2015
Equity, Class of Treasury Stock [Line Items]
Stock Repurchase Program, Authorized Amount			$ 35,000,000	$ 35,000,000
Purchase of treasury shares (in shares)	117,582	90,505
Repurchase of treasury shares	$ 7,004,000	$ 4,458,000
Remaining authorized amount for repurchase of common stock	50,303,000
Treasury stock reissued at lower than repurchase price	$ 5,667,000	$ 5,791,000

Deferred Compensation Plans - A

Deferred Compensation Plans - Additional Information (Detail) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jul. 01, 2016	Jun. 30, 2017	Jul. 01, 2016	Dec. 30, 2016
Deferred Compensation, Excluding Share-based Payments and Retirement Benefits
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]
Trading securities	$ 48,670,000		$ 48,670,000		$ 48,267,000
Deferred compensation plan vested amounts due	54,082,000		54,082,000		$ 53,617,000
Change in market value of trust assets	$ 1,020,000	$ 938,000	$ 2,917,000	$ 1,366,000
Maximum
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]
Percentage of compensation deferred			100.00%

Supplemental Disclosure of Cash

Supplemental Disclosure of Cash Flow Information (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jul. 01, 2016	Jun. 30, 2017	Jul. 01, 2016
Cash paid during period:
Income taxes			$ 8,522	$ 11,808
Non-cash investing and financing activities:
Unrealized gain on short-term investments	$ (32)	$ (1)	4	84
Vested stock unit awards issued to settle accrued bonuses			6,910	6,334
Accrual for capital expenditures			$ 135	$ 422

Accounts Receivable, Net (Detai

Accounts Receivable, Net (Detail) - USD ($) $ in Thousands	Jun. 30, 2017	Dec. 30, 2016
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for contract losses and doubtful accounts	$ (3,333)	$ (3,417)
Total accounts receivable, net	107,444	87,409
Billed accounts receivable
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts Receivable	72,915	60,510
Unbilled accounts receivable
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts Receivable	$ 37,862	$ 30,316

Segment Reporting - Additional

Segment Reporting - Additional Information (Detail)	3 Months Ended	6 Months Ended
	Jun. 30, 2017	Jun. 30, 2017	Jul. 01, 2016
Segment Reporting Information [Line Items]
Percentage of account receivable	10.00%	10.00%	10.00%
Percentage of Company's revenue	10.00%	10.00%	10.00%
Sales Revenue, Net [Member] | Customer Concentration Risk [Member]
Segment Reporting Information [Line Items]
Concentration Risk, Percentage	12.00%	12.00%
Accounts Receivable [Member]
Segment Reporting Information [Line Items]
Concentration Risk, Percentage	12.00%	12.00%

Segment Information (Detail)

Segment Information (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jul. 01, 2016	Jun. 30, 2017	Jul. 01, 2016
Segment Reporting Information [Line Items]
Revenues	$ 87,840	$ 77,295	$ 171,962	$ 160,451
Operating Income	20,317	14,931	34,951	31,367
Capital Expenditures	1,219	1,901	2,526	3,382
Depreciation and Amortization	1,629	1,524	3,195	2,927
Operating segments
Segment Reporting Information [Line Items]
Operating Income	30,137	23,589	57,937	49,922
Capital Expenditures	858	1,311	1,908	2,524
Depreciation and Amortization	1,207	1,161	2,363	2,225
Engineering and Other Scientific
Segment Reporting Information [Line Items]
Revenues	69,795	60,979	136,478	125,789
Operating Income	24,313	19,561	46,634	40,699
Capital Expenditures	794	1,273	1,802	2,463
Depreciation and Amortization	1,163	1,116	2,278	2,137
Environmental and Health
Segment Reporting Information [Line Items]
Revenues	18,045	16,316	35,484	34,662
Operating Income	5,824	4,028	11,303	9,223
Capital Expenditures	64	38	106	61
Depreciation and Amortization	44	45	85	88
Corporate
Segment Reporting Information [Line Items]
Operating Income	(9,820)	(8,658)	(22,986)	(18,555)
Capital Expenditures	361	590	618	858
Depreciation and Amortization	$ 422	$ 363	$ 832	$ 702